Back to search results

Supporting Adolescent Alcohol Treatment with Path180

This 8-week study is for teenagers aged 13 to 19 who are receiving mental health counseling or outpatient substance use treatment and have used alcohol in the past year. It tests a computer-based skills training program called Path180, designed specifically for teens. You would be randomly assigned to either receive your usual treatment or your usual treatment plus Path180. Researchers want to see if Path180 helps reduce heavy drinking days and if participants find the program satisfactory. The study aims to enroll 112 participants to understand if digital tools can improve treatment for young people with alcohol use disorder.

Study design
This is an interventional study with 112 participants. You would be randomly assigned to one of two groups: standard treatment or standard treatment plus Path180.
What's involved
If assigned to Path180, you would complete one module of the program at each of the first 7 weekly Check-in Visits. The active treatment phase lasts 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The study measures outcomes like heavy drinking days at the end of the 8-week active treatment phase (weeks 5-8).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07713251

Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training

Recruiting
NAAges 13–19InterventionalTreatment
Brown University
~112 participants
Updated 2026-07-20 on ClinicalTrials.gov
What's tested:Path180

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants who complete the active treatment phase
Measured over 8-week active treatment phase
+2 more outcomes measured

Conditions

Alcohol Use Disorder

Explore related trials

Alcohol use disorder

Where it's being run

1 sites across 1 states
Rhode Island1

Who to contact

Robert Miranda, PhD
[email protected]
401-863-6658
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ages 13 to 19 years, inclusive; we will exclude children \< 13 due to diversity across adolescence and youths \> 19 because our focus is teenagers
Seeking/receiving mental health counseling and/or outpatient substance use disorder treatment at Bradley Hospital or another national clinic/treatment service
Self-reported alcohol use in the past year
Meets criteria for a current DSM-5 alcohol use disorder assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS)
Able to understand written and oral instructions in English, communicate understanding of the consent/assent form, and provide written informed consent/assent
Complete all assessments required at screening.
Provide contact information of someone, such as a parent or other family member, who may be able to contact the participant in case of a missed study appointment or follow-up assessment.
Agree to the schedule of visits, verbally acknowledge that he/she/they will be able to attend each scheduled visit, participate in phone visits and that he/she/they does not have any already scheduled events or a job that may substantially interfere with study participation.
If younger than 18 years, permission from the minor's legal authorized representative (e.g., caregiver, parent) is required, herein referred to as parent permission.

Exclusion

Current significant alcohol withdrawal symptoms (score \> 10) on the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-AR); those with current significant alcohol withdrawal may be re-screened after stabilization
DSM-5 criteria for a severe SUD besides alcohol, cannabis and tobacco
Psychosis NOTE: Prospective participants diagnosed with psychiatric disorders not specifically excluded above may be included at the discretion of the principal investigator as long as the concurrent treatment for the comorbid psychiatric condition does not compromise the study integrity by virtue of its type, duration, or intensity.

What this trial measures

  • Number of participants who complete the active treatment phase8-week active treatment phase

    The number of participants who complete the active treatment phase will determine feasibility.

  • Number of Participants Who Rate Their Treatment Experience in the "Satisfactory" or "Highly Satisfactory" Range on the CSQ-88-week active treatment phase

    The Client Satisfaction Questionnaire (CSQ-8), which ranges in scores from 8 to 32 (higher scores indicate higher satisfaction), will determine acceptability. Treatment satisfaction will be considered acceptable if the number and percentage of subjects who rate their treatment experience in the "satisfactory" or "highly satisfactory" range on the CSQ-8 is ≥ 80%.

  • Number of heavy drinking daysLast 4 weeks of treatment (Weeks 5-8)

    Number of heavy drinking days (NHDD) during the last four weeks of treatment (treatment Weeks 5-8), as measured by the Timeline Followback interview. NHDD is defined as the total number of days on which participants consumed 5 or more drinks (for males) or 4 or more drinks (for females). The analysis of NHDD will control for baseline NHDD (defined as NHDD in the four weeks preceding treatment).